Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISTASEAL for hemostasis in liver surgery
NCT01754480Phase 3Completed
- Sponsor
- Grifols
- Start
- Mar 2013
- Primary completion
- Dec 2015
- Countries
- 4
01
Overview
Phase 3, randomised, single-blind trial of Fibrinogen human in Not applicable, sponsored by Grifols. Primary endpoint: Proportion of Subjects Achieving Hemostasis by Four Minutes After Treatment Start at 4 months. Started Mar 2013; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
Not applicable
Beyond the preview
Go deeper on NCT01754480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01754480.